Syndax Pharmaceuticals SNDX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $130.89M-15.0% | $134.93M-12.4% | $116.81M-12.2% | $108.64M+3.1% | $153.99M+34.4% | ||
| $221.17M-38.3% | $259.14M-38.1% | $319.17M+24.4% | $346.6M+8.4% | $358.2M+12.0% | ||
| $120.97M+419% | $98.58M+1,197% | $68.18M— | $42.78M— | $23.32M— | ||
| $110.4M+2,095% | $80.11M+21,789% | $47.73M— | $22.73M— | $5.03M— | ||
| $471.18M-14.1% | $528.08M-12.4% | $529.83M+27.7% | $531.68M+19.2% | $548.75M+20.9% | ||
| $177K— | $181K— | $128K— | $0-100% | $0-100% | ||
| $472.67M-26.2% | $529.71M-26.9% | $551.79M+29.6% | $596.15M+25.0% | $640.71M+18.0% | ||
| $10.84M+7.9% | $16.58M+42.6% | $13.83M+182% | $17.35M+50.0% | $10.05M+14.1% | ||
| $350M— | $350M— | $327.08M— | —— | —— | ||
| $86.17M-8.9% | $120.12M+16.0% | $114.19M+92.3% | $112.99M+166% | $94.55M+86.1% | ||
| $344.87M+4.2% | $344.96M+3.5% | $322.18M+16,108,650% | $325.74M+237,665% | $331.1M+99,031% | ||
| $431.05M+1.3% | $465.08M+6.5% | $436.36M+635% | $438.73M+930% | $425.65M+732% | ||
| $9K0.0% | $9K0.0% | $9K0.0% | $9K0.0% | $9K+12.5% | ||
| -$1.55B-18.6% | -$1.51B-23.4% | -$1.44B-27.6% | -$1.38B-32.1% | -$1.31B-34.0% | ||
| $41.62M-80.6% | $64.63M-77.6% | $115.43M-68.5% | $157.42M-63.8% | $215.06M-56.3% | ||
| $472.67M-26.2% | $529.71M-26.9% | $551.79M+29.6% | $596.15M+25.0% | $640.71M+18.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Syndax Pharmaceuticals's total assets?
- Syndax Pharmaceuticals (SNDX) holds $472.7M in total assets, down 26.2% year over year.
- How much debt does Syndax Pharmaceuticals have?
- Syndax Pharmaceuticals carries $350.5M in total debt against $41.6M of shareholders' equity, a debt-to-equity ratio of 8.42.
- How much cash does Syndax Pharmaceuticals have?
- Syndax Pharmaceuticals holds $130.9M in cash and equivalents.
- Can Syndax Pharmaceuticals cover its short-term obligations?
- Its current ratio is 5.47 — current assets exceed current liabilities.
- Where does Syndax Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Syndax Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
